Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the Week

J Am Coll Cardiol. 2020 Jun 16;75(23):2974-2983. doi: 10.1016/j.jacc.2020.04.009. Epub 2020 Apr 9.

Abstract

Patients with structural heart disease are at increased risk of adverse outcomes from the coronavirus disease-2019 (COVID-19) due to advanced age and comorbidity. In the midst of a global pandemic of a novel infectious disease, reality-based considerations comprise an important starting point for formulating clinical management pathways. The aims of these "crisis-driven" recommendations are: 1) to ensure appropriate and timely treatment of structural heart disease patients; 2) to minimize the risk of COVID-19 exposure to patients and health care workers; and 3) to limit resource utilization under conditions of constraint. Although the degree of disruption to usual practice will vary across the United States and elsewhere, we hope that early experiences from a heart team operating in the current global epicenter of COVID-19 may prove useful for others adapting their practice in advance of local surges of COVID-19.

Keywords: COVID-19; heart team; structural heart disease; valve center.

Publication types

  • Review

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Comorbidity
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / therapy
  • Critical Pathways* / organization & administration
  • Critical Pathways* / trends
  • Heart Diseases* / epidemiology
  • Heart Diseases* / surgery
  • Humans
  • Infection Control / methods*
  • Organizational Innovation
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / therapy
  • SARS-CoV-2